Ocugen | ClinicalTrials HQ

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Phase 3 Study to Assess Efficacy, Safety & Tolerability of OCU410 For Geographic Atrophy Secondary to Dry AMD	Dry Age-related Macular Degeneration	Recruiting	Phase 3	2026-08-19		NCT07770828
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa	Active, not recruiting	Phase 3	2026-07-31		NCT06388200
Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy	Geographic Atrophy, eye disorder, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 1 / Phase 2	2026-07-31		NCT06018558
A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder	Active, not recruiting	Phase 2 / Phase 3	2026-07-31		NCT05956626
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)	diabetic macular edema	Recruiting	Phase 1	2026-07-31		NCT05802329
Study to Assess the Safety and Efficacy of OCU400 for Retinitis Pigmentosa and Leber Congenital Amaurosis	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Leber congenital amaurosis, Meckel syndrome, type 4, congenital stationary night blindness autosomal dominant 1, enhanced S-cone syndrome, eye disorder, hereditary disease, inherited retinal dystrophy, retinal degeneration, retinal disorder, retinitis pigmentosa	Active, not recruiting	Phase 1 / Phase 2	2026-07-31		NCT05203939